A clinical trail to study the efficiency Of a coronary stent naTacrolimus Eluting Carbostent In Prevention Of Restenosis And Plaque Morphology
Phase 4
- Registration Number
- CTRI/2010/091/000511
- Lead Sponsor
- Dr. Maddury Jyotsna, Associate Professor of Cardiology, Department of Cardiology, NIMS, Panjagutta, Hyderabad, A.P., India-500 082
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
Patient with acute coronary syndrome (acute myocardial infarction or recent myocardial infarction with post MI angina or unstable angina - with in 15 days of event) admitted to hospital who are under going Percutaneous intervention are included.
Exclusion Criteria
1. Patients with thrombocytopenia or any other hematological abnormality.
2. Patient in cardiogenic shock.
3. Patients who refuses for tacrolimus eluting Carbostent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method MACE ( major cardivascular events) <br>Timepoint: 7 days, one month , 6 months and one year
- Secondary Outcome Measures
Name Time Method Quqntitative Coronary Angiogram wise luminal lossTimepoint: one year